Document is current
Any future updates will be listed below
-
Authors
Willoughby, Jennifer L. S.
George, Kelly
Roberto, Mark P.
Chin, Hang Gyeong
Stoiber, Patrick
Shin, Hyunjin
Pedamallu, Chandra Sekhar
Schaus, Scott E.
Fitzgerald, Kevin
Shah, Jagesh
Hansen, Ulla https://orcid.org/0000-0001-9803-4185
-
Funding
Funding for this research was provided by:
Alnylam Pharmaceuticals (NA)
Alnylam Pharmaceuticals (NA)
Boston University (NA)
Boston University (NA)
Boston University (NA)
Boston University Undergraduate Research Opportunity (NA)
New England Biolabs (NA)
National Institutes of Health (R01 GM078240)
- License Information
-
More Information
Article History
Received: 11 February 2020
Accepted: 4 June 2020
First Online: 6 July 2020
Ethics approval and consent to participate
: Not applicable.
: Not applicable.
: SES and UH are co-founders of Lamerigen, Inc. JLSW and KF are employed by Alnylam Pharmaceuticals. The remaining authors declare no potential conflict of interest.
